Skip to main content
Supplement ScienceSupplementScience

Omega-3 Dosage Guide

Evidence:Strong
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

General Dosage

1,000-2,000mg combined EPA+DHA daily (not total fish oil)

Maximum dose: 3,000mg EPA+DHA daily from supplements (FDA generally recognized as safe); up to 4g under medical supervision

Dosage Recommendations

General recommendation: 1,000-2,000mg combined EPA+DHA daily (not total fish oil)

Timing: With a fat-containing meal for optimal absorption • Take with food for best absorption.

Dosage by Condition

Heart health
1,000-2,000mg EPA+DHA daily; up to 4g EPA for high-riskStrong
Depression/mood
1,000-2,000mg with EPA-predominant formula (>60% EPA)Strong
Joint pain
2,000-3,000mg EPA+DHA dailyModerate
Brain health
1,000mg DHA-predominant dailyModerate

Upper limit: 3,000mg EPA+DHA daily from supplements (FDA generally recognized as safe); up to 4g under medical supervision

Timing & Absorption

With a fat-containing meal for optimal absorption

Best taken with food for optimal absorption.

Find a Omega-3 with the right dose
We verify actual dosage against clinical research
Full Omega-3 Guide

References

  1. RCTBhatt DL, Steg PG, Miller M, et al. (2019). Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. New England Journal of Medicine. DOI PubMed
  2. Meta-analysisLiao Y, Xie B, Zhang H, et al. (2019). Efficacy of omega-3 PUFAs in depression: A meta-analysis. Translational Psychiatry. DOI PubMed
  3. Calder PC (2017). Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochemical Society Transactions. DOI PubMed
  4. Dyall SC (2015). Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Frontiers in Aging Neuroscience. DOI PubMed
  5. Meta-analysisYan J, Liu M, Yang D, Zhang Y, et al. (2024). Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis.. Cardiovascular drugs and therapy. DOI PubMed
  6. Uchida Y, Tsuji K, Ochi E (2024). Effects of Omega-3 fatty acids supplementation and resistance training on skeletal muscle.. Clinical nutrition ESPEN. DOI PubMed
  7. Meta-analysisCalderon Martinez E, Zachariah Saji S, Salazar Ore JV, Borges-Sosa OA, et al. (2024). The effects of omega-3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systematic review and meta-analysis.. Neuropsychopharmacology reports. DOI PubMed
Show 4 more references
  1. Wang T, Zhang X, Zhou N, Shen Y, et al. (2023). Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose-Response Meta-Analysis of Randomized Controlled Trials.. Journal of the American Heart Association. DOI PubMed
  2. Wei BZ, Li L, Dong CW, Tan CC, et al. (2023). The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers.. The American journal of clinical nutrition. DOI PubMed
  3. Kelaiditis CF, Gibson EL, Dyall SC (2023). Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials.. Prostaglandins, leukotrienes, and essential fatty acids. DOI PubMed
  4. Meta-analysisDeng W, Yi Z, Yin E, Lu R, et al. (2023). Effect of omega-3 polyunsaturated fatty acids supplementation for patients with osteoarthritis: a meta-analysis.. Journal of orthopaedic surgery and research. DOI PubMed